Elizabeth Lowenthal, MD, MSCE
Dr. Lowenthal is a pediatric HIV specialist and clinical epidemiologist whose research work is primarily focused on pediatric global health. In particular, most of her research relates to the care and treatment of children and adolescents with HIV in resource-limited settings. Her comparative-effectiveness study of children receiving efavirenz-based or nevirapine-based antiretroviral therapy answered a question of great importance to the treatment of the more than three million HIV-infected children worldwide. Most of her current work is focused on adherence to HIV treatments among perinatally HIV-infected adolescents in Africa. Public health-focused aspects of her work are funded by a Centers for Disease Control-U.S. President's Emergency Plan for AIDS Relief (PEPFAR ) Public Health Effectiveness Grant; additional questions related to optimizing adherence measurement and defining developmental and psychosocial factors associated with non-adherence are funded by an NIH K23 Career Development award.
Dr. Lowenthal is involved with collaborative studies in multiple African countries. In addition, she is the co-PI for a pilot study assessing whether genetic differences in bitter taste receptors impact the tolerability of a protease inhibitor drug used commonly for the treatment of HIV-infected infants.
Global child health; pediatrics; HIV/AIDS; treatment adherence; HIV testing
Categorical data; health services research; multivariate analysis; survival analysis; cultural adaptation; validation of assessment tools; qualitative research